Chaperone-mediated autophagy in cancer: Advances from bench to bedside

Tao Hou1, Yizeng Fan1, Weichao Dan1

  • 1Department of Urology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Insights

Chaperone-mediated autophagy (CMA) is crucial for cell health and homeostasis. Recent studies reveal CMA

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Oncology

Background:

  • Chaperone-mediated autophagy (CMA) is a selective degradation pathway essential for cellular homeostasis.
  • Defects in CMA are linked to neurodegenerative diseases.
  • CMA activity is consistently increased in various cancer types, suggesting a role in tumorigenesis.

Purpose of the Study:

  • To review recent advances in understanding the molecular regulation of CMA.
  • To discuss the evidence linking CMA dysfunction to cancer development and progression.
  • To explore the potential of modulating CMA for cancer therapy.

Main Methods:

  • Literature review of recent studies on CMA.
  • Analysis of evidence connecting CMA activity to cancer cell lines and tumor biopsies.
  • Discussion of molecular mechanisms underlying CMA regulation.

Main Results:

  • CMA activity is elevated in numerous cancer types.
  • CMA plays a dual role: potentially anti-oncogenic in normal cells but pro-tumorigenic in cancer cells.
  • Evidence supports CMA dysfunction's contribution to cancer.

Conclusions:

  • CMA's complex role in cancer warrants further investigation.
  • Modulating CMA activity presents a potential therapeutic strategy for cancer.
  • Understanding CMA regulation is key to developing targeted cancer therapies.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.6K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.1K